Risatti; Guillermo R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Risatti; Guillermo R..The latest application filed is for "attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate".

Company Profile

0.9.5

Risatti; Guillermo R. - Westbrook CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate Grant 9,808,520 - Borca , et al. November 7, 2	2017-11-07
Attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate Grant 9,463,234 - Borca , et al. October 11, 2	2016-10-11
Live attenuated antigenically marked classical swine fever vaccine Grant 9,352,032 - Borca , et al. May 31, 2	2016-05-31
Attenuated African Swine Fever Virus Strain Induces Protection Against Challenge With Homologous Virulent Parental Virus Georgia 2007 Isolate App 20160082099 - Borca; Manuel V. ; et al.	2016-03-24
Live Attenuated Antigenically Marked Classical Swine Fever Vaccine App 20150250866 - Borca; Manuel V. ; et al.	2015-09-10
Virulence determinant within the E2 structural glycoprotein of classical swine fever virus Grant 8,846,055 - Borca , et al. September 30, 2	2014-09-30
N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine Grant 8,426,575 - Borca , et al. April 23, 2	2013-04-23
Live attenuated antigenically marked classical swine fever virus Grant 8,133,495 - Borca , et al. March 13, 2	2012-03-13
N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine App 20100104597 - Borca; Manuel ; et al.	2010-04-29
Live attenuated antigenically marked classical swine fever virus App 20080292653 - Borca; Manuel V. ; et al.	2008-11-27
Classical swine fever virus virulence determinant and a novel classical swine fever vaccine Grant 7,332,170 - Borca , et al. February 19, 2	2008-02-19
Novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus App 20070280955 - Borca; Manuel V. ; et al.	2007-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.